Turning physics into a scalable pipeline — and daring moonshots — to tackle the hardest-to-treat diseases

We are building not just a portfolio, but a repeatable, scalable engine for drug discovery. One capable of delivering innovative, hard-to-find therapies with speed, precision, and higher probability of success.

To maximize impact, we pursue two complementary approaches:

• Broad exploration: scanning multiple targets to identify the most promising opportunities.

  

• Indication-first “Moonshots”: programs focused on a single disease with high unmet medical need, running multiple shots on goal through different targets.

We partner with world-class CROs to ensure flawless execution without operating our own wetlab facilities.

Thanks to the scalability of QEMI — our fusion of fast physics and generative AI — we can pursue true Moonshots, setting us apart in the industry.